XXXX risk score in the diagnostic categories of @entity3610 .

@entity1 @entity3610 @entity283 @entity6 @entity2690 @entity164 @entity413
OBJECTIVE: To assess the Finnish @entity6 Risk Score in @entity3610 ( @entity3610 ) and in different phenotypes of @entity3610 and controls. DESIGN: Cross-sectional study. SETTING: General community. @entity1 (S): Overweight premenopausal @entity1 with @entity283 ( @entity283 ) @entity3610 (n = 29), non- @entity283 @entity3610 (n = 25), or controls (n = 27). INTERVENTION(S): No intervention provided. MAIN OUTCOME MEASURE(S): Finnish @entity6 Risk Score, anthropometrics, oral @entity413 tolerance test (OGTT), @entity413 , @entity2690 , and reproductive hormone levels. RESULT(S): The @entity1 with @entity283 @entity3610 had higher adiposity, abdominal adiposity and 120-minute OGTT @entity413 . The @entity1 with @entity283 and non- @entity283 @entity3610 had elevated 120-minute OGTT @entity2690 compared with controls. The @entity1 with @entity283 (11.3    0.7) and non- @entity283 @entity3610 (10.4    0.7) had similar @entity6 risk scores, but both had higher @entity6 risk score compared with controls (7.6    0.8) maintained on adjustment for age and body mass index (BMI). The @entity1 with @entity283 (4%) and non- @entity283 @entity3610 (12%) had a lower prevalence of low risk of @entity6 scores compared with controls (50%). CONCLUSION(S): We report for the first time that @entity1 with @entity283 and non- @entity283 @entity3610 have similar Finnish @entity6 Risk Scores and elevated scores relative to controls independent of age and adiposity. Similar clinical screening and treatment practices for @entity164 2 @entity6 are warranted for both phenotypes of @entity3610 .
